Oppenheimer & CO Inc Dyne Therapeutics, Inc. Transaction History
Oppenheimer & CO Inc
- $7.83 Billion
- Q3 2025
A detailed history of Oppenheimer & CO Inc transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Oppenheimer & CO Inc holds 11,364 shares of DYN stock, worth $198,188. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,364
Previous 34,674
67.23%
Holding current value
$198,188
Previous $330,000
56.67%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding DYN
# of Institutions
213Shares Held
125MCall Options Held
36.5KPut Options Held
74.3K-
Vanguard Group Inc Valley Forge, PA9.76MShares$170 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA9.71MShares$169 Million2.02% of portfolio
-
Janus Henderson Group PLC London, X09.44MShares$165 Million0.05% of portfolio
-
Atlas Venture Life Science Advisors, LLC9.13MShares$159 Million19.12% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$129 Million0.01% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $903M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...